EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trends in Leishmaniasis: A 32-Year Review in an Endemic Area in the South of Madrid Region

Víctor Antón-Berenguer iD, Óscar Manuel Muñoz Clemente, Beatriz López Quintana, Belén Martínez Mondéjar, Sara Moreno-García, Montserrat Chao Crecente iD, José Miguel Rubio Muñoz iD, Francisco Jesús Merino Fernández, Carmen Chicharro Gonzalo iD, Emilia García Díez, Francisco Javier Nieto Martínez, María Delmans Flores-Chávez iD

Pathogens · 2026

DOI: 10.3390/pathogens15020127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2026. Verfasst von Víctor Antón-Berenguer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Parasitology, Severo Ochoa University Hospital, Av. de Orellana, s/n, 28914 Leganés, Madrid, Spain. Hauptthemen laut MEDLINE: Leishmaniasis, Cutaneous, Leishmaniasis, Visceral, Leishmaniasis. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mundo Sano Foundation, collaboration agreement between the Mundo Sano Foundation and the CNM-ISCIII.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In Spain, Leishmania infantum causes both cutaneous (CL) and visceral leishmaniasis (VL). This study aimed to analyse trends in the clinical presentation, diagnosis, management, and epidemiology of leishmaniasis at Severo Ochoa University Hospital in Leganés, an endemic area in Southern Madrid affected by Europe’s largest outbreak (2009–2015). A retrospective study was conducted, including all confirmed cases from January 1992 to December 2024, using clinical records. Cases were stratified into pre-outbreak, outbreak, and post-outbreak periods. A total of 151 cases were identified, including 129 VL, 21 CL, and 1 simultaneous VL/CL. VL predominated among adults during the HIV epidemic, later shifting to elderly and non-HIV immunosuppressed patients, while paediatric cases remained stable. Diagnostic methods evolved from bone marrow microscopy, culture, and IFAT to molecular and chemiluminescence assays. VL treatment also evolved, with amphotericin B gradually replacing meglumine antimoniate as first-line VL treatment. Most patients required hospitalisation, with 8.5% mortality, mainly among immunocompromised or elderly individuals. A persistent concentration of cases near recently urbanised areas adjacent to the parks of Polvoranca and Bosquesur was observed. Despite advances in diagnosis and therapy, endemic transmission and underreporting continue, highlighting the need for ongoing surveillance and preventive measures. Hospital record review proved useful for monitoring compliance with mandatory VL notification, though its applicability to cutaneous cases remains limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmaniasis, CutaneousLeishmaniasis, VisceralLeishmaniasisHumansSpainRetrospective StudiesFemaleAdultMaleChildAntiprotozoal AgentsEndemic DiseasesAdolescentMiddle AgedChild, PreschoolAgedYoung AdultLeishmania infantumAmphotericin BMeglumine AntimoniateInfantDisease Outbreaks

Stichwörter der Autor:innen

LeishmaniaSpaincutaneous leishmaniasisepidemiological trendsimmunosuppressionoutbreakunderreportingvisceral leishmaniasis

Substanzen

Antiprotozoal AgentsAmphotericin BMeglumine Antimoniate

Autor:innen und Institutionen

  • Department of Microbiology and Parasitology, Severo Ochoa University Hospital, Av. de Orellana, s/n, 28914 Leganés, Madrid, Spain.
  • Department of Preventive Medicine, Severo Ochoa University Hospital, 28914 Leganés, Madrid, Spain.
  • Faculty of Medicine, Alfonso X El Sabio University, Av. de Orellana, s/n, 28911 Leganés, Madrid, Spain.
  • Department of Pathology, Severo Ochoa University Hospital, 28911 Leganés, Madrid, Spain.
  • Reference and Research Laboratory for Parasitology, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Ctra. Majadahonda-Pozuelo Km. 2, 28220 Majadahonda, Madrid, Spain.
  • Biomedical Research Centre for Infectious Diseases Network (CIBERINFEC-ISCIII), Ctra. Majadahonda-Pozuelo Km. 2, 28220 Majadahonda, Madrid, Spain.

ORCID-Profile: Víctor Antón-Berenguer, Montserrat Chao Crecente, José Miguel Rubio Muñoz, Carmen Chicharro Gonzalo, María Delmans Flores-Chávez

Förderung

  • Mundo Sano Foundation
  • collaboration agreement between the Mundo Sano Foundation and the CNM-ISCIII

Zitieren

APA

Antón-Berenguer, V., Muñoz Clemente, Ó. M., López Quintana, B., Martínez Mondéjar, B., Moreno-García, S., Chao Crecente, M., Rubio Muñoz, J. M., Merino Fernández, F. J., Chicharro Gonzalo, C., García Díez, E., Nieto Martínez, F. J., & Flores-Chávez, M. D. (2026). Trends in Leishmaniasis: A 32-Year Review in an Endemic Area in the South of Madrid Region. Pathogens. https://doi.org/10.3390/pathogens15020127

Vancouver

Antón-Berenguer V, Muñoz Clemente ÓM, López Quintana B, Martínez Mondéjar B, Moreno-García S, Chao Crecente M, et al. Trends in Leishmaniasis: A 32-Year Review in an Endemic Area in the South of Madrid Region. Pathogens. 2026. doi:10.3390/pathogens15020127

BibTeX
@article{AntnBerenguer2026,
  author = {Antón-Berenguer, Víctor and Muñoz Clemente, Óscar Manuel and López Quintana, Beatriz and Martínez Mondéjar, Belén and Moreno-García, Sara and Chao Crecente, Montserrat and Rubio Muñoz, José Miguel and Merino Fernández, Francisco Jesús and Chicharro Gonzalo, Carmen and García Díez, Emilia and Nieto Martínez, Francisco Javier and Flores-Chávez, María Delmans},
  title = {Trends in Leishmaniasis: A 32-Year Review in an Endemic Area in the South of Madrid Region},
  journal = {Pathogens},
  year = {2026},
  doi = {10.3390/pathogens15020127}
}
Kostenlos starten →